← All Biontech SE filings

Biontech SE 20-F annual reports

The annual report filed by foreign private issuers listed on a US exchange — the 10-K’s equivalent for non-US companies.

NASDAQ
BNTX
Biontech SE
20-F/A: BioNTech SE Files Amended Annual Report for Fiscal Year 2025
BioNTech SE has filed an amendment to its 2025 annual report, primarily to correct a typographical error in the auditor's opinion date and to include updated share count information.
NASDAQ
BNTX
Biontech SE
20-F/A: BioNTech Amends 20-F for Typo, Certifications
BioNTech SE filed an amendment to its 2025 annual report to correct an auditor's opinion date and include updated certifications, with no changes to financial data.
NASDAQ
BNTX
Biontech SE
20-F: BioNTech SE Releases Annual Report on Form 20-F for Fiscal Year 2024
BioNTech SE files its annual report on Form 20-F, detailing the company's business, operations, and financial performance for the year ended December 31, 2024.
NASDAQ
BNTX
Biontech SE
20-F: BioNTech Details Ordinary Shares and American Depositary Share Terms in SEC Filing
BioNTech's recent SEC filing outlines the terms and provisions of its ordinary shares and American Depositary Shares (ADSs), providing investors with a comprehensive overview of the company's capital structure and shareholder rights.